The largest database of trusted experimental protocols

4 protocols using α tubulin

1

Evaluating PAI-1 Inhibitor Effects on Extracellular Matrix

Check if the same lab product or an alternative is used in the 5 most similar protocols
At the end of treatment with PM2.5 in the absence and presence of PAI-1 inhibitor TM5614, supernatants from control and treated wells were collected. The cell lysates were prepared using RIPA lysis buffer (25 mM Tris•HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) (ThermoFisher Scientific) containing protease inhibitor cocktail (cOmplete) and phosphatase inhibitor cocktail (PhosSTOP) (Sigma). Cell lysates were pooled from 3 wells for each control and treatment group and equal amounts of protein were subjected to gel electrophoresis, transferred to PVDF membranes, and subjected to western blotting using antibodies against PAI-1 (Molecular Innovations, Inc.), type I collagen (Southern Biotech), fibronectin (Millipore), sterol regulatory element binding protein-1 and 2 (SREBP1, SREBP2), nuclear factor erythroid related factor 2 (Nrf2) (Abcam), and α-tubulin (GenScript), with HRP-tagged corresponding secondary antibodies. The membranes were developed with enhanced chemiluminescence reagents (Luminata Forte, Millipore, Billerica, MA), and images of protein bands were captured using a BIO-RAD ChemiDoc XRS system (BIO-RAD, CA).
+ Open protocol
+ Expand
2

Protein Interaction Analysis in Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Frozen heart or kidney tissues were submerged in tissue lysis buffer supplemented with protease inhibitor cocktail (cOmplete) and phosphatase inhibitor cocktail (PhosSTOP) (Sigma). Tissue lysates were prepared by homogenization using Pestle Mixer (Argos Tech.) and centrifugation at 10,000 rpm for 15 min at 4 °C. The supernatant was used as source of protein. Equal amount of heart or kidney tissue lysates from each mouse were pooled (n = 5) and loaded on 4–12% gradient gel. Equal amount of heart lysate proteins from each mouse (n = 4–5/group) were also subjected to western blot analysis. The proteins were transferred to PVDF membranes and processed for immunoblot analysis using antibodies against integrin αV, integrin β3 (Abcam), CBX7 (Abcam), Nrf2 (Abcam), pERK1/2, p-p38 (Cell Signaling) and α-tubulin (GenScript). For coupled immunoprecipitation and immunoblot assay, 1 mg of total heart tissue lysates pooled from 5 mice (200 μg/mouse) were immunoprecipitated with PAI-1 antibody (Molecular Innovations) and Protein A-Agarose beads overnight at 4 °C. The beads-bound proteins were spinned down and washed with lysis buffer for three times and beads were resuspended in LDS loading buffer (Invitrogen), denatured at 95 °C and loaded on 4–12% gradient gel and subjected to western blot using antibodies against integrin αV, integrin β3, protein phosphatase 1 (PP1), and PAI-1.
+ Open protocol
+ Expand
3

Immunoblotting of RBM4, α-tubulin, and GAPDH

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunoblotting was performed as described (Lin and Tarn, 2011 (link)). We used affinity-purified polyclonal antibodies against RBM4 (Lin and Tarn, 2011 (link)), α-tubulin (GenScript, Piscataway, NJ), glyceraldehyde 3-phosphate dehydrogenase (GAPDH; Proteintech, Rosemont, IL), and FLAG (Sigma-Aldrich).
+ Open protocol
+ Expand
4

Evaluating PAI-1 Inhibitor Effects on Extracellular Matrix

Check if the same lab product or an alternative is used in the 5 most similar protocols
At the end of treatment with PM2.5 in the absence and presence of PAI-1 inhibitor TM5614, supernatants from control and treated wells were collected. The cell lysates were prepared using RIPA lysis buffer (25 mM Tris•HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) (ThermoFisher Scientific) containing protease inhibitor cocktail (cOmplete) and phosphatase inhibitor cocktail (PhosSTOP) (Sigma). Cell lysates were pooled from 3 wells for each control and treatment group and equal amounts of protein were subjected to gel electrophoresis, transferred to PVDF membranes, and subjected to western blotting using antibodies against PAI-1 (Molecular Innovations, Inc.), type I collagen (Southern Biotech), fibronectin (Millipore), sterol regulatory element binding protein-1 and 2 (SREBP1, SREBP2), nuclear factor erythroid related factor 2 (Nrf2) (Abcam), and α-tubulin (GenScript), with HRP-tagged corresponding secondary antibodies. The membranes were developed with enhanced chemiluminescence reagents (Luminata Forte, Millipore, Billerica, MA), and images of protein bands were captured using a BIO-RAD ChemiDoc XRS system (BIO-RAD, CA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!